Rimiterol

Rimiterol
Clinical data
ATC code	R03AC05 (WHO) ;
Identifiers
	IUPAC name 4-{(S)-hydroxy[(2R)-piperidin-2-yl]methyl}benzene-1,2-diol;
CAS Number	32953-89-2 ;
PubChem CID	36283;
ChemSpider	33366 ;
UNII	26GIW6ZLPH;
ChEMBL	ChEMBL1097630 ;
CompTox Dashboard (EPA)	DTXSID70186603 ;
ECHA InfoCard	100.046.627
Chemical and physical data
Formula	C12H17NO3
Molar mass	223.272 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O[C@@H](c1ccc(O)c(O)c1)[C@@H]2NCCCC2;
	InChI InChI=1S/C12H17NO3/c14-10-5-4-8(7-11(10)15)12(16)9-3-1-2-6-13-9/h4-5,7,9,12-16H,1-3,6H2/t9-,12+/m1/s1 ; Key:IYMMESGOJVNCKV-SKDRFNHKSA-N ;
	(what is this?) (verify)

Rimiterol (INN/USAN) is a third-generation[1] short-acting[2][3] β₂ agonist.

References

Palma-Carlos AG, Palma-Carlos GS (April 1986). "Beta-2-agonists of third generation". Allergie et Immunologie. 18 (4): 31–2, 35. PMID 2899434.
Lai CK, Twentyman OP, Holgate ST (October 1989). "The effect of an increase in inhaled allergen dose after rimiterol hydrobromide on the occurrence and magnitude of the late asthmatic response and the associated change in nonspecific bronchial responsiveness". The American Review of Respiratory Disease. 140 (4): 917–23. doi:10.1164/ajrccm/140.4.917. PMID 2572192.
Ydreborg SO, Svedmyr N, Thiringer G (April 1977). "Comparison of rimiterol and terbutaline, given by aerosol, in a long-term study". Scandinavian Journal of Respiratory Diseases. 58 (2): 117–24. PMID 16339.

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.